Total phenolic and flavonoid contents and antioxidant, anti-inflammatory, analgesic, antipyretic and antidiabetic activities of Cordia myxa L. leaves

Background

Many plants of genus Cordia are traditionally used as astringent, anti-inflammatory, anthelminthic, antimalarial, diuretic, febrifuge, appetite suppressant and cough suppressant and to treat urinary infections, lung diseases and leprosy. The aim of the study is to determine the total phenolic and flavonoid contents of total ethanol extract and different fractions of C. myxa L. leaves, in addition to evaluation of some pharmacological activities including antioxidant, anti-inflammatory, analgesic, antipyretic and antidiabetic effects.

Methods

Air dried powder of C. myxa leaves were extracted using 95% ethanol and fractionated successively with petroleum ether, dichloromethane, ethyl acetate and finally with n-butanol. The fractions were concentrated and then investigated for their antioxidant, anti-inflammatory, analgesic, antipyretic and antidiabetic activities using phosphomolybidinum and DPPH assays, carrageenan-induced paw edema, hot plate, yeast -induced pyrexia and streptozotocin-induced hyperglycemia methods, respectively.

Results

The ethyl acetate fraction showed the highest antioxidant activity with high phenolic and flavonoid contents (31.03 ± 0.15 mg gallic acid equivalent/g dried weight and 811.91 ± 0.07 mg rutin equivalent/g dried weight, respectively). Dichloromethane and ethyl acetate fractions exhibited higher anti-inflammatory activity with percentages of inhibition 45.16% and 40.26%, respectively, which were quite comparable to that of indomethacin (51.61%). The petroleum ether and dichloromethane fractions showed the highest analgesic activity with reaction time 289.00 ± 3.00 and 288.33 ± 20.82, respectively. Evaluation of antipyretic activity revealed that the total ethanol extract and different fractions showed high antipyretic activities after 2 h, which were very close to that of the standard acetyl salicylic acid with a rapid onset (30 min). The total ethanol extract and the petroleum ether fraction exhibited the most potent hypoglycemic effect with a significant reduction in blood glucose level especially after 3 h to 95.67 ± 5.77 mg/dl and 87.67 ± 10.26 mg/dl, respectively and percentages decrease in blood glucose level were 68.22% and 70.78%, respectively.

Conclusion

Cordia myxa L. extract and fractions exhibited antioxidant, anti-inflammatory analgesic, antipyretic and antidiabetic activities which may be attributed by the presence of active phytoconstituents.

Boraginaceae (borage) family comprises about 2740 species distributed in 148 genera [1]. Various chemical constituents isolated and characterized from Boraginaceous plants, including pyrrolizidine alkaloids, naphthaquinones, flavonoids, terpenoids, triterpenoids and phenols [2]. Cordia is an important and representative genus of this family that could grow as trees, shrubs or sometimes subscandents [1]. The generic name honours a sixteenth century botanist, Valerius Cordus [3]. The genus Cordia originates from tropical and subtropical regions. About 300 species have been identified worldwide, mostly in the warmer regions. Cordia myxa (Syn. Cordia obliqua, Cordia crenata) is a medium sized deciduous tree about 10.5 m [4]. The chemical characteristics of this genus are the presence of quinones which are known as cordiaquinones [1]. Pyrrolizidine alkaloids are generally present as esters. More than 200 pyrrolizidine alkaloids have been isolated from these plants. Although these alkaloids are cytotoxic and cause poisoning, Cordia myxa was reported to contain the nontoxic alkaloid macrophylline [2].

The plant parts like fruits, leaves, stem bark, seeds and roots of most species of this genus, especially Cordia dichotoma, C. myxa, C. verbenacea, C. martinicensis, C. salicifolia, C. spinescens, C. latifolia, C. ulmifolia, among others, have long been used in traditional medicine as astringent, anti-inflammatory, anthelminthic, antimalarial, diuretic, febrifuge, appetite suppressant and cough suppressant and to treat urinary infections, lung diseases and leprosy. Cordia myxa fruits and seeds are also used as expectorants and effective in treating the diseases of the lungs. Raw fruits contain a gum which can be used beneficially in gonorrhea. They can remove pain from the joints and the burning of the throat, effective in treating the diseases of the spleen, and are used as a demulcent in southern Iran [1]. For this reasons the current study evaluate some pharmacological activities of total ethanol extract and different fractions of C. myxa L. leaves including antioxidant, anti-inflammatory, analgesic, antipyretic, antidiabetic and antimalarial effects.

Plant material

The leaves of C. myxa were collected from May to November 2015 from El-Orman botanical garden, Cairo, Egypt and identified by Prof. Dr. Nasser Barakat, Professor of Botany, Faculty of Science, Minia University. A voucher sample (Mn-Ph-Cog-023) was kept in the Herbarium of Pharmacognosy Department, Faculty of Pharmacy, Minia University, Minia, Egypt.

Preparation of the extract and fractions

The air dried powdered leaves (4.24 Kg) of C. myxa. Were extracted by maceration with 95% ethanol at room temperature with occasional agitation for 7 days till exhaustion, and then concentrated under reduced pressure till dryness. The concentrated ethanol extract (275 g) was suspended in the least amount of distilled water, transferred to a separating funnel and partitioned successively by liquid/liquid extraction with petroleum ether, dichloromethane, ethyl acetate and finally with n-butanol. The fractions were concentrated under reduced pressure at 40 °C to afford petroleum ether (107 g), dichloromethane (13.2 g), ethyl acetate (11.74 g) and n-butanol (49.92 g) fractions.

Animals

The animals used in this study include female and male albino rats weighing 200 ± 50 g and mice weighing 30 ± 5 g, obtained from animal house of Faculty of Medicine, Assiut University. They were housed under standardized environmental conditions, and fed with standard diet and water. The study was conducted following approval by the Institutional Animal Ethical Committee of Faculty of Pharmacy, Minia University, Minia, Egypt.

Acute toxicity

The acute toxicity of the total ethanolic extract of Cordia myxa leaves was evaluated by measuring the lethal dose for 50% of the laboratory animals (LD₅₀) [5]. Different dose levels (1, 2, 2.5, 3 up to 3.5 g/ kg, p.o) of the total ethanolic extract (suspended in 0.5% CMC) were orally administrated to different groups of mice (30 ± 5 g, each containing six mice). The control group received an equivalent dose of the vehicle (0.5% CMC). Both the test and control groups were noticed for 24 h under normal environmental conditions, with free access to food and water.

Evaluation of antioxidant study

Each sample was dissolved in 95% methanol to make a concentration of 40 mg/ml from total ethanolic extract and different fractions except the ethyl acetate fraction which was prepared as 10 mg/ml and then diluted to prepare the series concentrations for antioxidant assays.

Estimation of total phenolic content

The content of total phenolic compounds for total ethanol extract and different fractions of C. myxa leaves were determined by Folin–Ciocalteu method [6]. Analysis was performed by adding 3.5 ml of deionized water, 50 μl of sample extract, 50 μl Folin-Ciocalteu reagent (2 N) and 300 μl of sodium carbonate (10%). The reaction was left for 30 min. and then the absorbance was measured in triplicate at 730 nm. The blank consisted of all reagents excluding the sample extract. A standard curve was made using gallic acid so that total phenolic concentration was expressed as mg of gallic acid equivalents per gram dried fraction.

Estimation of total flavonoid content

Total flavonoid content was determined following a method in literature [6], where 0.3 ml of extracts, 3.4 ml of 30% methanol, 0.15 ml of NaNO₂ (0.5 M) and 0.15 ml of AlCl₃.6H₂O (0.3 M) were mixed. After 5 min, 1 ml of NaOH (1 M) was added. The solution was mixed well and the absorbance was measured in triplicate against the reagent blank at 506 nm. The standard curve for total flavonoids was made using rutin standard solution at different concentration under the same procedure. The total flavonoid content was expressed as milligrams of rutin equivalents per gram of dried fraction.

Phosphomolybdate assay (total antioxidant capacity)

The total antioxidant capacity of the fractions was determined by phosphomolybdate method using ascorbic acid as a standard [6]. An aliquot of 0.3 ml of sample solution was mixed with 3 ml of reagent solution (0.6 M sulphuric acid, 28 mM sodium phosphate and 4 mM ammonium molybdate). The tubes were capped and incubated in a water bath at 95 °C for 90 min. After the samples had cooled to room temperature, the absorbance of the mixture was measured at 695 nm against a blank. A typical blank contained 3 ml of the reagent solution and the appropriate volume of the solvent and incubated under the same conditions. A standard curve was made using ascorbic acid; hence, the antioxidant activity was expressed relative to that of ascorbic acid. All determinations were done in triplicate.

DPPH radical scavenging activity assay

The free radical scavenging activity of the fractions was measured using 1,1- diphenyl-2-picryl-hydrazyl (DPPH) [6]. Briefly, 200 μl of each of the extract or fractions at various concentrations was added to 2 ml of DPPH solution (0.1 mM), The reaction mixture was shaken well and incubated in the dark for 15 min at room temperature. Methanol was used instead of the extract and fractions as a control. Then the absorbance was measured in triplicate at 517 nm. The capability to scavenge the DPPH radical was calculated using the following equation:

DPPH scavenging effect (%) = [(A₀ -A₁/A₀) × 100].

Where A₀ was the absorbance of the control reaction and A₁ equal the absorbance in the presence of the extract. The extract concentration providing 50% inhibition (IC₅₀) was calculated from the graph of DPPH scavenging effect against extract concentration.

Anti-inflammatory activity

The total ethanol extract and different fractions of C. myxa leaves were evaluated for their anti-inflammatory activity using the carrageenan-induced paw edema method [7]. Female albino rats (200 ± 50 g) were randomly divided into seven groups (six animals per group). The specified dose of extract, fractions, and standard drug were suspended in 0.5% CMC solution. The –ve control group administered the vehicle (0.5% CMC solution), while the standard drug indomethacin (+ve control) was given orally at a dose level of 8 mg/kg. The total ethanol extract and different fractions were administered orally at a dose of 350 mg/kg through 2 h after carrageenan injection 0.1 ml, 1% w/v in normal saline, s.c.) into the sub-plantar tissue of the right hind paw. The paw thickness (mm) was measured using a vernier calliper at 0, 0.5, 1, 2, 3, 4 and 5 h after administration of the tested extract, fractions and standard drug. The percentage inhibition of the rat paw edema was calculated as follows [8]:

Analgesic activity

The analgesic activity of the total ethanol extract and different fractions of C. myxa L. leaves was evaluated using hot plate method [9]. Mice (30 ± 5 g) were grouped into seven groups (six animals each). The –ve control group administered the vehicle (0.5% CMC solution) and the standard drug paracetamol 100 mg/kg, p.o. (+ve control). The tested extract and different fractions were suspended in 0.5% CMC solution and were administered orally at a dose level of 350 mg/kg. The animals were placed on a hot plate and the temperature of the metal surface was maintained at 54 °C. The time (sec) of the response produced by the animal as tail withdrawn, licking paws or jumping due to radient heat is noted and recorded at 0, 0.5, 1, 2, 3, 4 and 5 h after the administration of the tested extract, fractions and the standard drug.

The percentage of protection against thermal stimulus was calculated as follows [10]:

Antipyretic activity

The total ethanol extract and different fractions of C. myxa L. leaves were evaluated for their antipyretic activity using yeast-induced pyrexia method [11, 12]. The test was performed on female albino rats (200 ± 50 g) by subcutaneous injection (in the back, below the nape of the neck) of 20% aqueous suspension of yeast in a dose of 10 ml/kg to induce pyrexia. The pyretic animals were grouped into seven groups (six animals each). The –ve control group orally administered the vehicle (0.5% CMC solution), while the +ve control was given the reference drug acetylsalicylic acid at a dose level of 330 mg/kg, p.o). The tested extract and different fractions were suspended in 0.5% CMC solution and were administered orally at a dose level of 350 mg/kg through 2 h after yeast injection. The rectal temperature of each animal was recorded by inserting a thermometer 2 cm into the rectum at 0, 0.5, 1, 2, 3, 4 and 5 h following the administration of the tested extract, fractions and the reference drug.

Anti-diabetic activity

The total ethanol extract and different fractions of C. myxa L. leaves were evaluated for their anti-diabetic effects using streptozotocin-induced hyperglycemia method [12]. The test was performed on adult male albino rats (200 ± 50 g) by intraperitoneal injection of streptozotocin (80 mg/kg). Blood glucose level was measured after 3 days up to 1 week for assessment of hyperglycemia. Rats with blood glucose level above (200 mg/dl) were considered to be diabetic and were used in this study. The diabetic rats were divided into seven groups (six rats each). The control group was administered the vehicle (0.5% CMC solution) and the standard drug vildagliptin 50 mg/kg p.o. (+ve control). The tested extract and different fractions were suspended in 0.5% CMC solution and were orally administered at a dose level of 350 mg/kg. Blood glucose levels were measured at intervals of 0 (fasting), 0.5, 1, 2, 3, 4 and 5 h by collecting blood samples from the tail vein (caudal vein). The percentage of change in blood glucose level was calculated by the following formula [12, 13]:

Statistical analysis

Results of all biological studies were expressed as means ± S.E.M. One-way analysis of variance (ANOVA) followedby Dunnett’s test was used to determine significance when compared to the control group. p values less than 0.05, 0.01, and 0.001 were considered significant (*p < 0.05, **p < 0.01,*** p < 0.001). Graph Pad Prism 5 was used for statistical calculations (Graph pad Software, San Diego California, USA).

Acute toxicity

Concerning the safety of C. myxa L. plant, a preliminary toxicity study showed no mortality up to a dose level of 2500 mg/Kg and this was in accordance with published data which reported that both the leaves and the fruits are safe and edible in India and other countries [14, 15].

Evaluation of antioxidant study

Estimation of total phenolic content

The content of total phenolic compounds of the total ethanol extract and the different fractions of C. myxa L. leaves was determined by Folin– Ciocalteu method. The results were shown in Table 1 and Additional file 1.

Results were varied widely, ranging from 4.54 ± 0.04 to 31.03 ± 0.15 mg gallic acid equivalent/g dried weight. The highest amount of phenols was found in the ethyl acetate fraction (31.03 ± 0.15), followed by the dichloromethane, total extract, petroleum ether and n-butanol fractions (8.81 ± 0.04), (5.76 ± 0.23), (4.75 ± 0.22) and (4.54 ± 0.04), respectively.

Estimation of total flavonoid content

The total flavonoid content of the total ethanol extract and different fractions of C. myxa L. leaves was determined and the results were shown in Table 2 and Additional file 2, where they varied widely, ranging from 13.09 ± 0.11 to 811.91 ± 0.07 mg rutin equivalent/g dried weight. The highest amounts of flavonoids was.

found in the ethyl acetate fraction (811.91 ± 0.07) followed by the dichloromethane fraction (295.45 ± 0.13), the total extract (192.24 ± 0.33), the n-butanol fraction (84.29 ± 0.017) and lastly the petroleum ether fraction which contained remarkably lower amounts of these compounds (13.09 ± 0.11).

Phosphomolybdate assay (total antioxidant capacity)

The total ethanol extract and the different fractions of C. myxa L. leaves showed varied antioxidant capacity. The highest antioxidant capacity was displayed by the ethyl acetate fraction (103.40 ± 0.05) mg of ascorbic acid equivalent/g dried weight. The other fractions and the total ethanol extract showed mild antioxidant capacities, where the butanol fraction showed the lowest capacity (12.58 ± 0.60) mg of ascorbic acid equivalent/g dried fraction. The results of phosphomolybdate assay were listed in Table 3 and illustrated in Additional file 3.

DPPH radical scavenging activity assay

By analyzing the antioxidant activity of the total ethanol extract and the different fractions of C. myxa L. leaves, it was demonstrated that all showed dose-dependent antioxidant activity. Results were listed in Table 4 and illustrated in Additional file 4. The ethyl acetate fraction was the most effective DPPH free radical scavenger with IC₅₀ with a value of 0.03 ± 0.01 mg/ml. The other fractions and the total ethanol extract showed higher IC₅₀, thus lower DPPH radical scavenging activity, where the total ethanol extract exhibited the lowest DPPH radical scavenging activity with IC₅₀ value of 1.33 ± 0.03 mg/ml as compared with BHT (0.96 ± 0.03 μg/ml) as a positive control.

Anti-inflammatory activity

It is obvious from Tables 5 and 6 and Additional file 5 that the percentages of edema inhibition varied within the different fractions and the total extract. A gradual increase was observed for the first 4 h, then, the activity started to decline again. The highest anti-inflammatory activity was observed after 3 h in the total extract and after 4 h for the rest of the fractions, while the standard showed this activity after both the third and fourth hour from administration. After 3 h, the dichloromethane fraction showed moderate anti-inflammatory activity with a percentage of inhibition (40.26%), while, after 4 h, both the dichloromethane and the ethyl acetate fractions showed higher anti-inflammatory activity with percentages of inhibition (45.16%) and (40.26%), respectively, which were quite comparable to that of indomethacin (51.61%). The total extract and the butanol fraction showed mild inhibition of the inflammation that was increased by time to be 19.35% and 25.81%, respectively, after 4 h. On the other hand, the least activity was shown by the petroleum ether fraction throughout the 5 h of the experiment.

Analgesic activity

The results of the analgesic activity of the total ethanol extract and different fractions of C. myxa L. leaves revealed that the total ethanol extract and all fractions exhibited potent analgesic activity compared to the control but less than the used standard paracetamol (Tables 7 and 8 and Additional file 6). One hour from the beginning of the experiment, the total ethanol extract, petroleum ether and dichloromethane fractions significantly increased the reaction time (106.33 ± 3.06***), (191.00 ± 31.08**) and (170.33 ± 21.39**), respectively. After 3 h, the petroleum ether and dichloromethane fractions showed the highest analgesic activity (289.00 ± 3.00***) and (288.33 ± 20.82***), respectively. They increased the reaction time more than three times as that of the –ve control. The total extract showed moderate analgesic activity. It increased the reaction time double that of the control. The ethyl acetate and butanol fractions showed slight analgesic activities compared to other fractions.

Antipyretic activity

The results of the antipyretic activity of the total ethanol extract and different fractions of C. myxa L. leaves revealed that the total ethanol extract and most of the fractions exhibited a significant (p < 0.001) antipyretic activity up to 4 h (Table 9 and Additional file 7). After 2 h, the total ethanol extract, the petroleum ether, the dichloromethane and the ethyl acetate fractions showed high antipyretic activities which were very close to that of the standard acetyl salicylic acid with a rapid onset (30 min). The antipyretic activity lasted up to 4 h. The butanol fraction showed antipyretic activity with a slower onset after 2 h which also lasted for 4 h.

Anti-diabetic activity

From the mentioned results in (Tables 10 and 11 and Additional file 8) the total ethanol extract and petroleum ether fraction showed potent anti-diabetic effect with a significant decrease in blood glucose level with a rapid onset (30 min). Their effects were increased gradually until reaching the highest level after 3 h, and then a gradual decline was demonstrated for the rest of experiment. The total ethanol extract and the petroleum ether fraction were the most potent. They showed a significant reduction in blood glucose level especially after 3 h 95.67 ± 5.77***mg/dl and 87.67 ± 10.26***mg/dl, respectively. Also the percentage decrease in blood glucose level was (68.22%) and (70.78%), respectively, which demonstrates their close resemblance to the standard vildagliptin (78.69%). The dichloromethane fraction also showed a moderate gradual reduction in blood glucose level up to 121.67 ± 3.06*** mg/dl after 2 h with a percentage decrease of (42.79%) while both ethyl acetate and butanol fractions showed no anti-diabetic activity throughout the experiment time.

Safety of C. myxa was evaluated and results confirmed the previous published data [14, 15]. The ethyl acetate fraction showed the highest antioxidant activity compared to the total ethanol extract and other fractions. This activity may be attributed to its high content of flavonoids and other phenolic compounds as phenyl propanoids. The total ethanol extract and dichloromethane fraction exhibited highest anti-inflammatory activities compared to indomethacin. Many mechanisms were proved for anti-inflammatory activity of flavonoids, such as: inhibition of cyclooxygenase and 5- lipoxygenase pathways, and inhibition of eicosanoid biosynthesis, together with their ability to inhibit neutrophil degradation [16]. The potent antipyretic activity of the total extract and different fractions of C. myxa L. may be attributed to its content of flavonoids and sterols [17]. Analgesic activity may be attributed to their content of sterols which were reported to have analgesic activity [18]. Finally; the hypoglycaemic effect is in accordance with reported literature [19] for the total ethanol extract which proved that the hypoglycemic mechanism is throughout the inhibition of α-glucosidase enzyme. Thus it can decrease blood glucose level or inhibit glucose absorption.

The present study confirmed that total ethanol extract and different fractions of C. myxa leaves showed significant antioxidant, antiinflammatory, analgesic, antipyretic and antidiabetic activities in different in vitro and in vivo experimental models, which are in accordance with folk medicine of many Cordia plants. The presence of high content of flavonoids and other phenolic compounds in the ethyl acetate fraction might have some role in the observed pharmacological activities. In addition, the acute toxicity does not show any symptoms, changes in behavior or mortality at 2.5 g/kg doses that indicate a therapeutic safety for the doses pharmacologically active. The further detailed investigation is ongoing to determine the exact bioactive phytoconstituents that are responsible for those actions of this plant as traditional medicine. Moreover, it could be a potential source for discovery of antioxidant, antiinflammatory, analgesic, antipyretic and antidiabetic drug development.

Not applicable.

C. myxa :

Cordia myxa

CMC:

Carboxy methyl cellulose

DPPH:

2,2-diphenyl-1-picrylhydrazyl

IC₅₀ :

Inhibitory concentration 50

p.o.:

Taken orally

s.c:

Subcutaneous

Not applicable

Funding

There hadn’t any funding supports for carrying this research.

Affiliations

1. Department of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia, Egypt

   • Enas R. Abdel-Aleem
   • , Eman Z. Attia
   • , Fatma F. Farag
   • , Mamdouh N. Samy
   •  & Samar Y. Desoukey

Contributions

ERA performed all of the experiments in the laboratory and data collection, analysis, graphical representation and interpretation. EZA did critical statistical analysis and experiments. FFF did experiment design and overall monitoring. Critical revision of the article was done by MNS. Conception, experiment design, overall monitoring and final approval of the article was done by SYD. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mamdouh N. Samy.

Ethics approval and consent to participate

The study was approved by the Institutional Animal Ethical Committee of Faculty of Pharmacy, Minia University, Minia, Egypt.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reprints and Permissions